ICH: Assembly Meeting 2024 Recap
Key highlights include:
- ICH welcomed three new Observers: CPPS (Uzbekistan), DIGEMID (Peru), and Thai FDA (Thailand), bringing the total to 23 Members and 38 Observers.
- Progress on guideline development:
- Draft ICH E6(R3) Annex 2 on Good Clinical Practice reached Step 2a/b.
- Draft ICH M15 on Model-Informed Drug Development reached Step 2a/b.
- ICH M13A on Bioequivalence for Immediate-Release Solid Oral Dosage Forms reached Step 4.
- ICH E11A on Pediatric Extrapolation reached Step 4. - MedDRA (Medical Dictionary for Regulatory Activities) updates:
- Dr. Craig Simon from Health Canada elected as MedDRA Management Committee Vice-Chair.
- MedDRA Version 27.1 now available in 24 languages.
- Publication of MedDRA Points to Consider Companion Document Version 3.0 which features a new section on Manufacturing and Quality System Issues - Training Activities:
- Published ICH E8(R1) "General Considerations for Clinical Studies" Introductory Training Video
- Updated training materials for ICH Q8/Q9/Q10 Guidelines - ICH awarded the 2025 DIA Regional Inspire Award for Outstanding Contribution to Global Health.
- The next ICH Assembly Meeting is scheduled for May 13-14, 2025, in Madrid, Spain.
Source:
ICH: News
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
